Patents by Inventor Eric Scott LIGHTCAP

Eric Scott LIGHTCAP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of sting agonist and checkpoint inhibitors
    Patent number: 12403154
    Abstract: The present disclosure provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient in need a STING (stimulator of interferon genes) agonist, such as Compound No. 14, or a pharmaceutically acceptable salt thereof, in combination with one or more checkpoint inhibitors. Suitable checkpoint inhibitors include anti-PD-1 antibodies, anti-PD-L1 antibodies and anti-CTLA-4 antibodies. Also provided are medicaments for use in treating cancer. Compound No.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: September 2, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Eric Scott Lightcap, Yosuke Sato
  • ADMINISTRATION OF STING AGONIST AND CHECKPOINT INHIBITORS
    Publication number: 20220257630
    Abstract: The present disclosure provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient in need a STING (stimulator of interferon genes) agonist, such as Compound No. 14 as defined in the description, or a pharmaceutically acceptable salt thereof, in combination with one or more checkpoint inhibitors. Also provided are medicaments for use in treating cancer.
    Type: Application
    Filed: July 9, 2020
    Publication date: August 18, 2022
    Inventors: Eric Scott LIGHTCAP, Yosuke SATO